Bracco-Eisai Joint Venture: a shared vision

Bracco-Eisai Co., Ltd. was established in 1990 under the Joint Venture Agreement between Bracco Imaging Holding B.V., the world leading company in the diagnostic imaging area, and Eisai Co., Ltd., a global pharmaceutical company in Japan.

We import/produce high quality pharmaceutical products in diagnostic imaging area, and provide them in the Japanese market through Eisai Co., Ltd. in order to offer various solutions to the patients as well as medical experts. Over the years we have provided eminent contrast media for X-Ray/CT and MRI. We believe that our most important mission is to make patients to have diagnostic imaging tests in safety, as well as appropriate diagnostic information which can lead to effectual treatment.

Highlights

1990

Founded Bracco-Eisai Joint Venture in Japan

1994

Launched the non-ionic iodinated contrast agent in the X-Ray/CT market

1996

Established Saitama plant at Honjo City, Saitama Prefecture

1999

Succeeded the import approval of macrocylcic non-ionic contrast agent for MRI

2015

The 25th Anniversary of the foundation